Jianhua Chao

1.1k total citations
19 papers, 558 citations indexed

About

Jianhua Chao is a scholar working on Oncology, Organic Chemistry and Immunology. According to data from OpenAlex, Jianhua Chao has authored 19 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Organic Chemistry and 6 papers in Immunology. Recurrent topics in Jianhua Chao's work include Chemokine receptors and signaling (7 papers), Multicomponent Synthesis of Heterocycles (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Jianhua Chao is often cited by papers focused on Chemokine receptors and signaling (7 papers), Multicomponent Synthesis of Heterocycles (4 papers) and Cytokine Signaling Pathways and Interactions (4 papers). Jianhua Chao collaborates with scholars based in United States, United Kingdom and South Korea. Jianhua Chao's co-authors include Jason D. Fontenot, David Huss, Geoffrey O. Gillard, Robert H. Scannevin, Brian Collette, John E. Anderson, Xuedong Fan, Daniel Lundell, Michael P. Dwyer and R. William Hipkin and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Nature Chemical Biology and Tetrahedron Letters.

In The Last Decade

Jianhua Chao

19 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianhua Chao United States 13 200 195 193 141 59 19 558
Nayoung Lee United States 14 159 0.8× 222 1.1× 267 1.4× 153 1.1× 15 0.3× 46 718
Alexandre Patenaude Canada 14 93 0.5× 395 2.0× 94 0.5× 110 0.8× 23 0.4× 23 661
Irida Kastrati United States 14 56 0.3× 376 1.9× 203 1.1× 176 1.2× 26 0.4× 35 771
Thao Perry United States 9 107 0.5× 281 1.4× 66 0.3× 155 1.1× 16 0.3× 10 562
J S Lazo United States 13 57 0.3× 322 1.7× 171 0.9× 46 0.3× 36 0.6× 19 789
Bartosz J. Zieba Poland 9 156 0.8× 325 1.7× 305 1.6× 38 0.3× 20 0.3× 12 655
Keshav Karki United States 13 116 0.6× 278 1.4× 73 0.4× 57 0.4× 18 0.3× 19 476
Pierre Antony France 14 109 0.5× 225 1.2× 30 0.2× 69 0.5× 165 2.8× 20 537
Shaheen Khan United States 12 184 0.9× 317 1.6× 63 0.3× 125 0.9× 11 0.2× 14 727
Liwei Weng United States 14 64 0.3× 371 1.9× 43 0.2× 121 0.9× 19 0.3× 24 674

Countries citing papers authored by Jianhua Chao

Since Specialization
Citations

This map shows the geographic impact of Jianhua Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianhua Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianhua Chao more than expected).

Fields of papers citing papers by Jianhua Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianhua Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianhua Chao. The network helps show where Jianhua Chao may publish in the future.

Co-authorship network of co-authors of Jianhua Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Jianhua Chao. A scholar is included among the top collaborators of Jianhua Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianhua Chao. Jianhua Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chao, Jianhua, Kelsie J. Green, Eun‐Kyung Choi, et al.. (2024). Minimizing higher-order aggregation maximizes iron mobilization by small molecules. Nature Chemical Biology. 20(10). 1282–1293. 2 indexed citations
2.
Enyedy, Istvan, Noel A. Powell, Justin A. Caravella, et al.. (2016). Discovery of biaryls as RORγ inverse agonists by using structure-based design. Bioorganic & Medicinal Chemistry Letters. 26(10). 2459–2463. 12 indexed citations
3.
Banerjee, Daliya, Tonika Bohnert, Jianhua Chao, et al.. (2015). Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2985–2990. 27 indexed citations
4.
Chao, Jianhua, Istvan Enyedy, D.J. Marcotte, et al.. (2015). Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2991–2997. 27 indexed citations
5.
Gillard, Geoffrey O., Brian Collette, John E. Anderson, et al.. (2015). DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner. Journal of Neuroimmunology. 283. 74–85. 147 indexed citations
6.
Banerjee, Daliya, Linlin Zhao, Lan Wu, et al.. (2015). Small molecule mediated inhibition of RORγ‐dependent gene expression and autoimmune disease pathology in vivo. Immunology. 147(4). 399–413. 33 indexed citations
7.
Ishchenko, Alexey, Lin Zhang, Junhua Fan, et al.. (2014). Structure-based design of low-nanomolar PIM kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(3). 474–480. 17 indexed citations
8.
Tam, Betty Y., Cheryl Black, Deping Wang, et al.. (2012). Synthesis, SAR and biological evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as dual inhibitors of Aurora kinases and CDK1. Bioorganic & Medicinal Chemistry Letters. 22(5). 2070–2074. 35 indexed citations
9.
Tam, Betty Y., Deping Wang, D.J. Marcotte, et al.. (2012). Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(12). 4033–4037. 23 indexed citations
10.
Taveras, Arthur G., Michael P. Dwyer, Younong Yu, et al.. (2009). Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2–CXCR1 dual antagonists. Bioorganic & Medicinal Chemistry Letters. 19(5). 1431–1433. 13 indexed citations
11.
Chao, Jianhua, et al.. (2009). Synthesis of functionalized hydroxy-thiophene motifs as amido- and sulfonamido-phenol bioisosteres. Tetrahedron Letters. 50(35). 5005–5008. 7 indexed citations
12.
Chao, Jianping, Michael P. Dwyer, Younong Yu, et al.. (2009). Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region. Bioorganic & Medicinal Chemistry Letters. 19(15). 4446–4449. 8 indexed citations
13.
Merritt, J. Robert, Daming Feng, Jianhua Chao, et al.. (2008). Synthesis and structure–activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(6). 1864–1868. 8 indexed citations
14.
Taveras, Arthur G., Younong Yu, Junying Zheng, et al.. (2007). 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 18(1). 228–231. 16 indexed citations
15.
Chao, Jianhua, Arthur G. Taveras, Jianping Chao, et al.. (2007). C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(13). 3778–3783. 38 indexed citations
16.
Gonsiorek, Waldemar, Xuedong Fan, David Hesk, et al.. (2007). Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist. Journal of Pharmacology and Experimental Therapeutics. 322(2). 477–485. 101 indexed citations
17.
Chao, Jianhua, et al.. (2006). A two-step procedure for the preparation of mono-protected bis-N-heterocyclic alkyl ether systems. Tetrahedron Letters. 48(5). 791–794. 5 indexed citations
18.
Chao, Jianhua, et al.. (1999). Genotoxic effects of triphenyltin acetate and triphenyltin hydroxide on mammalian cells in vitro and in vivo. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 444(1). 167–174. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026